bluebird bio Announces September Investor Events

Rhea-AI Summary

bluebird bio (Nasdaq: BLUE) has announced its participation in two upcoming investor conferences in September. The company's management team will engage in fireside chats at the following events:

1. 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, at 12:45 p.m. ET at the Encore Boston Harbor, Everett, MA.

2. Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, at 5:35 p.m. ET at the New York Marriott Marquis, New York, NY.

Investors can access live webcasts of these fireside chats through the 'Events & Presentations' page on bluebird bio's website. Replays will be available for 90 days following the events.

Positive

• Participation in high-profile healthcare investor conferences
• Live webcasts of fireside chats available to investors
• 90-day replay availability of webcasts on company website

Negative

• None.

SOMERVILLE, Mass.--(BUSINESS WIRE)-- bluebird bio, Inc. (Nasdaq: BLUE) today announced that members of the management team will participate in fireside chats at the following upcoming investor conferences:

• 2024 Wells Fargo Healthcare Conference, Wednesday, September 4, at 12:45 p.m. ET at the Encore Boston Harbor, Everett, MA
• Morgan Stanley 22nd Annual Global Healthcare Conference, Thursday, September 5, at 5:35 p.m. ET at the New York Marriott Marquis, New York, NY

To access the live webcast of bluebird bio’s fireside chats, please visit the “Events & Presentations” page within the Investors & Media section of the bluebird bio website at http://investor.bluebirdbio.com. Replays of the webcasts will be available on the bluebird bio website for 90 days following the events.

About bluebird bio, Inc.

bluebird bio is pursuing curative gene therapies to give patients and their families more bluebird days.

Founded in 2010, bluebird has been setting the standard for gene therapy for more than a decade—first as a scientific pioneer and now as a commercial leader. bluebird has an unrivaled track record in bringing the promise of gene therapy out of clinical studies and into the real-world setting, having secured FDA approvals for three therapies in under two years. Today, we are proving and scaling the commercial model for gene therapy and delivering innovative solutions for access to patients, providers, and payers.

With a dedicated focus on severe genetic diseases, bluebird has the largest and deepest ex-vivo gene therapy data set in the field, with industry-leading programs for sickle cell disease, β-thalassemia and cerebral adrenoleukodystrophy. We custom design each of our therapies to address the underlying cause of disease and have developed in-depth and effective analytical methods to understand the safety of our lentiviral vector technologies and drive the field of gene therapy forward.

bluebird continues to forge new paths as a standalone commercial gene therapy company, combining our real-world experience with a deep commitment to patient communities and a people-centric culture that attracts and grows a diverse flock of dedicated birds.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240828846235/en/

Investors:

Courtney O’Leary, 978-621-7347

coleary@bluebirdbio.com

Media:

Jess Rowlands, 857-299-6103

jess.rowlands@bluebirdbio.com

Source: bluebird bio, Inc.

FAQ

When and where is bluebird bio (BLUE) presenting at the Wells Fargo Healthcare Conference?

bluebird bio (BLUE) is presenting at the Wells Fargo Healthcare Conference on Wednesday, September 4, at 12:45 p.m. ET at the Encore Boston Harbor in Everett, MA.

What time is bluebird bio's (BLUE) fireside chat at the Morgan Stanley Global Healthcare Conference?

bluebird bio's (BLUE) fireside chat at the Morgan Stanley Global Healthcare Conference is scheduled for Thursday, September 5, at 5:35 p.m. ET.

How long will the webcasts of bluebird bio's (BLUE) investor conference presentations be available?

The webcasts of bluebird bio's (BLUE) investor conference presentations will be available for replay on the company's website for 90 days following the events.

Where can investors access the live webcasts of bluebird bio's (BLUE) September investor events?

Investors can access the live webcasts of bluebird bio's (BLUE) September investor events on the 'Events & Presentations' page within the Investors & Media section of the company's website at http://investor.bluebirdbio.com.